Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation The RE-DUAL PCI Trial Subanalysis

ten Berg Jurrien M.; de Veer Anne; Oldgren Jonas; Steg Philippe Gabriel; Zateyshchikov Dmitry A.; Jansky Petr; Seung Ki-Bae; Hohnloser Stefan H.; Lip Gregory Y. H.; Nordaby Matias; Kleine Eva; Bhatt Deepak L.; Cannon Christopher P.

首页> 外文期刊>JACC. Cardiovascular interventions >Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation The RE-DUAL PCI Trial Subanalysis

【24h】

Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation The RE-DUAL PCI Trial Subanalysis

机译：心房颤动患者PCI后口服抗凝治疗切换重新双PCI试验细胞分析

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

OBJECTIVES The aim of this study was to assess if prior oral anticoagulant agent (OAC) usemodifies the lower bleeding risk observed with dabigatran dual therapy (dabigatran twice daily plus a P2Y(12) inhibitor) versus warfarin triple therapy (warfarin plus a P2Y12 inhibitor plus aspirin) in patients with atrial fibrillation who underwent percutaneous coronary intervention (PCI).

机译：本研究的目的是评估先前的口服抗凝药剂（OAC），使用Dabigatran双治疗（Dabigatran每日两次P2Y（12）抑制剂）观察到较低的出血风险（Dabigatran）与华法林三重治疗（Warfarin加上P2Y12抑制剂加上阿司匹林）在经皮冠状动脉介入（PCI）的心房颤动患者中。

著录项

来源
《JACC. Cardiovascular interventions》 |2019年第23期|共11页
作者
ten Berg Jurrien M.; de Veer Anne; Oldgren Jonas; Steg Philippe Gabriel; Zateyshchikov Dmitry A.; Jansky Petr; Seung Ki-Bae; Hohnloser Stefan H.; Lip Gregory Y. H.; Nordaby Matias; Kleine Eva; Bhatt Deepak L.; Cannon Christopher P.;
展开▼
作者单位

St Antonius Hosp Nieuwegein Netherlands;

St Antonius Hosp Nieuwegein Netherlands;

Uppsala Univ Uppsala Clin Res Ctr Uppsala Sweden;

Dept Hospitalouniv FIRE French Alliance Cardiovasc Trials Paris France;

City Clin Hosp 51 Primary Vasc Dept Moscow Russia;

Fac Hosp Motol Dept Cardiovasc Surg Prague Czech Republic;

Catholic Univ Korea Seoul South Korea;

Goethe Univ Frankfurt Frankfurt Germany;

Univ Liverpool Liverpool Ctr Cardiovasc Sci Liverpool Merseyside England;

Boehringer Ingelheim Int Ingelheim Germany;

Boehringer Ingelheim Int Ingelheim Germany;

Brigham &

Womens Hosp Heart &

Vasc Ctr 75 Francis St Boston MA 02115 USA;

Brigham &

Womens Hosp Heart &

Vasc Ctr 75 Francis St Boston MA 02115 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内科学;
关键词
atrial fibrillation; bleeding event; dabigatran dual therapy; oral anticoagulant agents; OAC; switching OACs;

机译：心房颤动;出血事件;Dabigatran双重治疗;口服抗凝剂;OAC;切换OACS;

相似文献

外文文献
中文文献
专利

1. Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation The RE-DUAL PCI Trial Subanalysis [J] . ten Berg Jurrien M., de Veer Anne, Oldgren Jonas, JACC. Cardiovascular interventions . 2019,第23期

机译：心房颤动患者PCI后口服抗凝治疗切换重新双PCI试验细胞分析
2. Comparison of the Effect of Age ( = 75) on the Efficacy and Safety of Dual Therapy (Dabigatran plus Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin plus Aspirin plus Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the RE-DUAL PCI Trial) [J] . ten Berg Jurrien M., Steg Philippe Gabriel, Bhatt Deepak L., The American Journal of Cardiology . 2020,第5期

机译：年龄（= 75）对白治疗（Dabigatran Plus Clopidogrel或TiCagrelel）的疗效和安全性的比较（Dabigatran Plus氯吡格雷或TiCagrelor）对心房颤动后心房颤动患者的三重治疗（Warfarin Plus Aspirin Plus Clopidogrel或TiCagrelel）（来自RE -Dual PCI试验）
3. Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial [J] . Oldgren Jonas, Steg Philippe Gabriel, Hohnloser Stefan H., European Heart Journal: The Journal of the European Society of Cardiology . 2019,第19期

机译：Dabigatran双重治疗用冠状动脉介入在心房颤动患者中有或没有急性冠状动脉综合征的经皮冠状动脉介入作用：亚组分析来自重新双PCI试验
4. Experimental research of microsecond plasma interrupting switch (PCIS). Canal concept of PCIS operation [C] . Dolgachev G. I., Zakatov L. P., Ushakov A. G. Electromagnetic Compatibility Symposium Record, 1968 IEEE . -1

机译：微秒等离子体中断开关（PCIS）的实验研究。 PCIS手术的运河概念
5. Early Identification and Intervention in Patients with Atrial Fibrillation Using an Implantable Cardiac Monitor to Significantly Improve Guideline-Based Anticoagulation Therapy in an Outpatient Cardiology Clinic [D] . Alvarez, Lisa 2019

机译：使用可植入式心脏监护仪对房颤患者的早期识别和干预，可显着改善门诊心脏病学诊所基于指南的抗凝治疗
6. Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial [O] . José C. Nicolau, Deepak L. Bhatt, Stefan H. Hohnloser, -1

机译：达比加群双重疗法与华法林三次疗法在有/无质子泵抑制剂的房颤患者中经皮冠状动脉介入治疗后的疗效：RE-DUAL PCI试验的预先分析
7. Safety and efficacy of non–vitamin K oral anticoagulant for atrial fibrillation patients after percutaneous coronary intervention: A bivariate analysis of the PIONEER AF-PCI and RE-DUAL PCI trial [O] . Gerald Chi, Mathieu Kerneis, Arzu Kalayci, 2018

机译：经皮冠状动脉干预后心房颤动患者的非维生素K口服抗凝剂的安全性和有效性：先驱AF-PCI和重新双PCI试验的双重分析

Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation The RE-DUAL PCI Trial Subanalysis

摘要

著录项

相似文献

相关主题

期刊订阅